Skip to main content

Cloning for Profit

When San Francisco-based Genetic Savings and Clone announced in December it had sold a cloned kitten to a Texas woman, the public seemed caught between feelings of revulsion and excitement over the idea of cloning the family pet.

Written byIvan Oransky
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00

Courtesy of Victor Fisher/Polaris

Genetic Savings and Clone's cat manager, Leslie Ungerer and CEO Lou Hawthorne present "Little Nicky" to a Dallas, Texas, resident who paid $50,000 for the kitten.

When San Francisco-based Genetic Savings and Clone announced in December it had sold a cloned kitten to a Texas woman, the public seemed caught between feelings of revulsion and excitement over the idea of cloning the family pet. The Maine Coon cat's genetic replica, dubbed Little Nicky, was not the first cat ever cloned; the company had already cloned four. However, it was the first to be sold commercially, and it will hardly be the last.

Now that cat cloning is a possibility, at least half a dozen companies say they are planning commercial cloning operations. In addition, some companies are focusing on cloning technology rather than producing clones themselves, such as Westport, Conn.-based Aurox. Others, such as Bryan, Texas-based ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Published In

The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad
Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

bioxcell
Scientist reviewing cellular and molecular data on a computer in a laboratory.

Building Translation-Ready Biomarkers with Connected Workflows

Danaher Logo

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays